Jean‐Marc Orgogozo

9.5k total citations · 2 hit papers
81 papers, 6.6k citations indexed

About

Jean‐Marc Orgogozo is a scholar working on Psychiatry and Mental health, Physiology and Epidemiology. According to data from OpenAlex, Jean‐Marc Orgogozo has authored 81 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 22 papers in Physiology and 17 papers in Epidemiology. Recurrent topics in Jean‐Marc Orgogozo's work include Dementia and Cognitive Impairment Research (31 papers), Alzheimer's disease research and treatments (18 papers) and Acute Ischemic Stroke Management (16 papers). Jean‐Marc Orgogozo is often cited by papers focused on Dementia and Cognitive Impairment Research (31 papers), Alzheimer's disease research and treatments (18 papers) and Acute Ischemic Stroke Management (16 papers). Jean‐Marc Orgogozo collaborates with scholars based in France, United Kingdom and United States. Jean‐Marc Orgogozo's co-authors include Jean‐François Dartigues, Pascale Barberger‐Gateau, Hélène Amieva, Luc Letenneur, Colette Fabrigoule, Catherine Helmer, Karine Pérès, Nicolas Le Carret, Hélène Jacqmin‐Gadda and F. Forette and has published in prestigious journals such as The Lancet, PLoS ONE and Brain.

In The Last Decade

Jean‐Marc Orgogozo

80 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial

2005 992 citations F. Forette, Jean‐Marc Orgogozo et al. profile →
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

2002 521 citations Luc Letenneur, Jean‐Marc Orgogozo et al. profile →

Peers

Countries citing papers authored by Jean‐Marc Orgogozo

Since Specialization

Citations

This map shows the geographic impact of Jean‐Marc Orgogozo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marc Orgogozo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marc Orgogozo more than expected).

Fields of papers citing papers by Jean‐Marc Orgogozo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marc Orgogozo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marc Orgogozo. The network helps show where Jean‐Marc Orgogozo may publish in the future.

Co-authorship network of co-authors of Jean‐Marc Orgogozo

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marc Orgogozo. A scholar is included among the top collaborators of Jean‐Marc Orgogozo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marc Orgogozo. Jean‐Marc Orgogozo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Analysis of the Public Financial Support Eligibility Rule for French Dependent Elders with Alzheimer’s Disease 2015 ·Value in Health ·Thomas Rapp, Loretto Lacey, Pierre‐Jean Ousset, (unknown), Bruno Vellas, Jean‐Marc Orgogozo	6
2	Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: a study of 20 years of cognitive decline 2014 ·Brain ·Hélène Amieva, (unknown), Mélanie Le Goff, Céline Meillon, Hélène Jacqmin‐Gadda, Alexandra Foubert‐Samier, Jean‐Marc Orgogozo, Yaakov Stern, Jean‐François Dartigues	209
3	Paquid 2012: illustration and overview 2012 ·Gériatrie et Psychologie Neuropsychiatrie du Viellissement ·Jean‐François Dartigues, Catherine Helmer, Luc Letenneur, Karine Pérès, Hélène Amieva, Sophie Auriacombe, Jean‐Marc Orgogozo, Daniel Commenges, Hélène Jacqmin‐Gadda, S. Richard‐Harston, Fleur Delva, Alexandra Foubert‐Samier, Pascale Barberger‐Gateau	6
4	Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study 2012 ·The Lancet Neurology ·Bengt Winblad, Niels Andreasen, Lennart Minthon, (unknown), Georges Imbert, Thomas Dumortier, R. P. Maguire, Kaj Blennow, (unknown), Matthias Staufenbiel, Jean‐Marc Orgogozo, Ana Graf	234
5	Assessment of quality of life in stroke patients with hemiplegia 2011 ·Annals of Physical and Rehabilitation Medicine ·(unknown), (unknown), (unknown), Michèle Koleck, Patrick Dehail, Jean‐Marc Orgogozo, Jean‐Michel Mazaux	43
6	Stroke in the under-75S: Expectations, concerns and needs 2009 ·Annals of Physical and Rehabilitation Medicine ·(unknown), Patrick Dehail, Jean‐Christophe Daviet, Gilles Lamothe, (unknown), Jean‐Marc Orgogozo, J.-M. Mazaux	13
7	Relevance of the Evaluation Criteria Used in Clinical Trials for Alzheimer’s Disease 2009 ·Therapies ·Philippe Truffinet, Régis Bordet, Joël Ménard, Serge Bakchine, Luc Buée, (unknown), (unknown), Bruno Dubois, Françoise Duveau, Jean‐Marie Goehrs, (unknown), (unknown), (unknown), Jean‐Marc Orgogozo, Florence Pasquier, (unknown), Franck Semah, Jacques Touchon, Marc Verny, Mohammed Zaïm	5
8	Inter‐ and intraobserver reliability of five MRI sequences in the evaluation of the final volume of cerebral infarct 2009 ·Journal of Magnetic Resonance Imaging ·Igor Sibon, Patrice Ménégon, Jean‐Marc Orgogozo, Julien Asselineau, François Rouanet, Pauline Renou, Thomas Tourdias, Chahin Pachaï, Geneviève Chêne, Vincent Dousset	9
9	Safety and Tolerability of the Rivastigmine Patch 2009 ·Alzheimer Disease & Associated Disorders ·George T. Grossberg, Carl Sadowsky, Hans Förstl, Lutz Frölich, (unknown), Sibel Tekin, (unknown), Jacqueline Ros, Jean‐Marc Orgogozo	36
10	Gender and education impact on brain aging: A general cognitive factor approach. 2008 ·Psychology and Aging ·Cécile Proust‐Lima, Hélène Amieva, Luc Letenneur, Jean‐Marc Orgogozo, Hélène Jacqmin‐Gadda, Jean‐François Dartigues	113
11	Empfehlungen der Europäischen Schlaganfall-Initiative zur Versorgung und Behandlung des Schlaganfalls 2001 ·Der Nervenarzt ·Werner Hacke, Markku Kaste, Tom Skyhøj Olsen, Jean‐Marc Orgogozo, Julien Bogousslavsky	8
12	Acute Treatment of Ischemic Stroke 2000 ·Cerebrovascular Diseases ·Werner Hacke, Markku Kaste, Tom Skyhøj Olsen, Julien Bogousslavsky, Jean‐Marc Orgogozo	77
13	Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project 1999 ·Journal of Neurology Neurosurgery & Psychiatry ·Luc Letenneur, V. Gilleron, Daniel Commenges, Catherine Helmer, Jean‐Marc Orgogozo, Jean‐François Dartigues	298
14	Analysis of Error Types in the Trail Making Test Evidences an Inhibitory Deficit in Dementia of the Alzheimer Type 1998 ·Journal of Clinical and Experimental Neuropsychology ·Hélène Amieva, Sylviane Lafont, Sophie Auriacombe, Constant Rainville, Jean‐Marc Orgogozo, Jean‐François Dartigues, (unknown)	61
15	Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. 1997 ·PubMed ·Serge Gauthier, N. Bodick, (unknown), Howard Feldman, David Geldmacher, (unknown), Richard C. Mohs, Jean‐Marc Orgogozo, Stephanie Rogers	22
16	Vin, alcool et accidents vasculaires cérébraux : données épidémiologiques 1996 ·Sang thrombose vaisseaux ·Jean‐Marc Orgogozo, Jean‐François Dartigues, (unknown)	2
17	Meta-Analysis of Oral Nimodipine Trials in Acute Ischemic Stroke 1994 ·Cerebrovascular Diseases ·J.P. Mohr, Jean‐Marc Orgogozo, M.J. Harrison, Michael G. Hennerici, Nils Wahlgren, (unknown), Eduardo Martínez‐Vila, (unknown), D Tettenborn	106
18	CBM 36‐733 (2‐Methyl‐alpha‐ergokryptine) In primary degenerative dementia: Results of a european multicentre trial 1988 ·International Journal of Geriatric Psychiatry ·W Danielczyk, (unknown), F. Forette, Jean‐Marc Orgogozo, (unknown), (unknown), Matteo Floris, Roy Levy, Michael Philpot, Jennifer Cox, (unknown), Pierrette Seeldrayers	1
19	Anti‐Acetylcholine Antibodies and the Pathogenesis of Myasthenia Gravis^a 1987 ·Annals of the New York Academy of Sciences ·(unknown), M. Geffard, (unknown), P Lebrun-Grandié, Jean‐Marc Orgogozo	3
20	Etude Analytique et Quantitative des Troubles du Langage par Lesion du Thalamus Gauche: L'aphasie Thalamique 1982 ·Cortex ·Jean‐Michel Mazaux, Jean‐Marc Orgogozo	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact